The study drug is being developed as a possible treatment for people living with chronic hepatitis B

Study number 5939 - RECRUITMENT CURRENTLY ON HOLD
Group People living with chronic hepatitis B infection
Gender Male / Female
Age 18 - 65
Location Liverpool
Compensation Reasonable travel expenses will be paid upon a valid receipt
Recruiting from Oct 2019
Additional details Study visits – between 13-20 (including screening)